Cargando…

TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

BACKGROUND: The highly refractory nature of non-small cell lung cancer (NSCLC) to chemotherapeutic drugs is an important factor resulting in its poor prognosis. Recent studies have revealed that tumour necrosis factor alpha-induced protein 8 (TNFAIP8) is involved in various biological and pathologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Ying, Liu, Yuechao, Liu, Tianbo, Meng, Qingwei, Lu, Hailing, Liu, Wei, Hu, Jing, Li, Chunhong, Cao, Mengru, Yan, Shi, Huang, Jian, Wang, Ting, Cai, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069800/ https://www.ncbi.nlm.nih.gov/pubmed/30064446 http://dx.doi.org/10.1186/s12964-018-0254-x

Ejemplares similares

TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
por: Ma, Hong-Yu, et al.
Publicado: (2020)

Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
por: Ma, Hong-Yu, et al.
Publicado: (2023)

TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1
por: Pang, Yihua, et al.
Publicado: (2020)

TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA
por: Zhang, Shuai, et al.
Publicado: (2022)

TNFAIP8 variants as potential epidemiological and predictive biomarkers in ovarian cancer
por: Gao, Hongyu, et al.
Publicado: (2020)

Association of TNFAIP8 gene polymorphisms with endometrial cancer in northern Chinese women
por: Liu, Tianbo, et al.
Publicado: (2019)

TNFAIP8 modulates the survival and immune activity of Th17 cells via p53/ p21/ MDM2 pathway after acute insult
por: Cheng, Xiaobin, et al.
Publicado: (2022)

miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
por: Chen, Xuesong, et al.
Publicado: (2016)

Susceptibility of TNFAIP8, TNFAIP8L1, and TNFAIP2 Gene Polymorphisms on Cancer Risk: A Comprehensive Review and Meta-Analysis of Case–Control Studies
por: Bhowmik, Khokon Kanti, et al.
Publicado: (2022)

Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation
por: Tracz-Gaszewska, Zuzanna, et al.
Publicado: (2017)

TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation
por: Niture, Suryakant, et al.
Publicado: (2020)

TNFAIP8: Inflammation, Immunity and Human Diseases
por: Niture, Suryakant, et al.
Publicado: (2019)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
por: Ning, Yichong, et al.
Publicado: (2019)

MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
por: Qi, Dong-Lai, et al.
Publicado: (2016)

Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer
por: Kamoshida, S, et al.
Publicado: (2007)

MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
por: Chen, Xin, et al.
Publicado: (2019)

TNFAIP3 is anti-inflammatory in the retinal vasculature
por: Liu, Li, et al.
Publicado: (2022)

TNFAIP8 promotes prostate cancer cell survival by inducing autophagy
por: Niture, Suryakant, et al.
Publicado: (2018)

8-Triazolylpurines: Towards Fluorescent Inhibitors of the MDM2/p53 Interaction
por: Pettersson, Mariell, et al.
Publicado: (2015)

Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry
por: Zhu, Yan, et al.
Publicado: (2013)

Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate Cancer Cells In-Vitro
por: Gupta, Amit, et al.
Publicado: (2019)

MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation
por: Hirose, Mitsuaki, et al.
Publicado: (2014)

The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation
por: Wang, Hao, et al.
Publicado: (2018)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Regulation of kidney development by the Mdm2/Mdm4–p53 axis
por: El-Dahr, Samir, et al.
Publicado: (2017)

VPS33B suppresses lung adenocarcinoma metastasis and chemoresistance to cisplatin
por: Liu, Zhen, et al.
Publicado: (2020)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
por: Li, Yang, et al.
Publicado: (2020)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

Heterogeneous Hydration of p53/MDM2 Complex
por: Guo, Zuojun, et al.
Publicado: (2014)

CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma
por: Zhang, Yongzhen, et al.
Publicado: (2018)

A p53/lnc‐Ip53 Negative Feedback Loop Regulates Tumor Growth and Chemoresistance
por: Zhang, Li‐Zhen, et al.
Publicado: (2020)

TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT
por: Zhong, Mengya, et al.
Publicado: (2020)

Fortifying p53 – beyond Mdm2 inhibitors
por: Sriraman, Anusha, et al.
Publicado: (2016)

Kidney tubular epithelial cells control interstitial fibroblast fate by releasing TNFAIP8-encapsulated exosomes
por: Liu, Xi, et al.
Publicado: (2023)

Oncogenic Role of Tumor Necrosis Factor α-Induced Protein 8 (TNFAIP8)
por: Niture, Suryakant, et al.
Publicado: (2018)

TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner
por: Jiang, Jie, et al.
Publicado: (2021)

Mir‐1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53
por: Wang, Xinyan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pj24ok05ouf6g9v4ojs2q44rc6